Delivery Order SPE2DB24D1021-SPE2DB25FEWHS

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,059.76, is for the delivery of 4,567,967,841 units of the medication Multaq 400 mg tablet in 60-count packages. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,090,331 units of the medication Multaq 400 mg tablet, with a ceiling value of $1,686.78. The contract is a firm fixed-price delivery order with a period of performance through May 1, 2025. No set-aside designation is mentioned, indicating this was an open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,373.43, is for the delivery of Multaq 400 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,248.92 firm fixed-price contract is for the supply of 4,568,090,212 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,019.92, is for the delivery of 4,567,874,049 units of the prescription medication Multaq 400 mg tablet. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not set aside and was awarded on April 10, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,248.41, is for the delivery of the prescription drug Multaq 400 mg tablets. It is a firm fixed-price contract with a completion date of May 8, 2025. The contract is not set aside and is considered an open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,344.94, is for the delivery of the medication Multaq 400 mg tablet 60s. It is a firm-fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,044.70, is a delivery order for the medication Multaq 400 mg tablet 60s. It is a firm fixed-price contract with a completion date of May 5, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,282.96 firm fixed-price contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,584.20 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,440,564 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEWHS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,474.42 firm fixed-price contract is for the delivery of 4,568,087,561 units of the prescription medication Multaq 400 mg tablet. The contract has a performance period through May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for federal agencies including the Defense Health Agency and U.S. Coast Guard. This delivery order is not designated as a set-aside contract, indicating open competition. The contract aligns with DLA's role in supplying diverse medical products and pharmaceuticals to support military and government healthcare programs.

Generated 8/3/25, 1:23 AM